Note: This document contains side effect information about azilsartan medoxomil. Some dosage forms listed on this page may not apply to the brand name Edarbi.
Applies to azilsartan medoxomil: oral tablet.
Warning
Oral route (Tablet)
Discontinue use of azilsartan medoxomil as quickly as possible if pregnancy is detected as drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.
Serious side effects of Edarbi
Along with its needed effects, azilsartan medoxomil (the active ingredient contained in Edarbi) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking azilsartan medoxomil:
Rare
- Blurred vision
- confusion
- dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
- sweating
- unusual tiredness or weakness
Other side effects of Edarbi
Some side effects of azilsartan medoxomil may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Less common
- Diarrhea
Rare
- Cough
- dizziness
- lack or loss of strength
- muscle spasm
- nausea
For Healthcare Professionals
Applies to azilsartan medoxomil: oral tablet.
General
The most common side effects were diarrhea, dizziness, headache, dyslipidemia, cough, and increased blood creatine phosphokinase.[Ref]
Gastrointestinal
Common (1% to 10%): Diarrhea
Uncommon (0.1% to 1%): Nausea[Ref]
Nervous system
Common (1% to 10%): Dizziness, headache
Frequency not reported: Dizziness postural[Ref]
Metabolic
Common (1% to 10%): Dyslipidemia
Uncommon (0.1% to 1%): Blood uric acid increased, hyperuricemia[Ref]
Respiratory
Common (1% to 10%): Cough[Ref]
Musculoskeletal
Common (1% to 10%): Blood creatine phosphokinase increased
Uncommon (0.1% to 1%): Muscle spasm[Ref]
Dermatologic
Uncommon (0.1% to 1%): Rash, pruritus
Rare (less than 0.1%): Angioedema[Ref]
Other
Uncommon (0.1% to 1%): Fatigue, peripheral edema
Frequency not reported: Asthenia[Ref]
Hematologic
Uncommon (0.1% to 1%): Low hemoglobin, low hematocrit, low RBC counts[Ref]
Renal
Uncommon (0.1% to 1%): Blood creatinine increased[Ref]
Cardiovascular
Uncommon (0.1% to 1%): Hypotension[Ref]
